1. Home
  2. Financial Impact Hub
  3. COVID-19: Essential market insight and resources

Stay current

COVID-19: Essential market insight and resources

Navigate rapid market shifts with our​ expert data-driven insights and news.

There seems to be a light at the end of the tunnel with the news of a vaccine roll out across the globe. However, COVID-19 is still impacting countries and global markets. We are here to help you navigate these extraordinary market challenges with our breadth and depth of expert data.

Leverage Refinitiv's trusted data, market-leading insights and technology to navigate the rapid market shifts as you look for ways ahead - and count on our products to make sense of the unfolding financial crisis. Feel confident in the decisions you make with Refinitiv at your side.

How we can help

Track the global impact of Coronavirus with Eikon

To help navigate the markets with trusted and real-time data and insight on COVID-19, we have enhanced our products and curated insights.

Our Macro Vitals app provides a comprehensive set of data, news, charts and insight recording the economic impact of the coronavirus pandemic. Following the success of our Novel coronavirus and Macro Vitals Apps we decided to capture the best features of both Apps and combine them into one. This will make it easier for customers to access pandemic related information as well as extensive content and analytics on the impact that the virus is having on the global economy. Type ‘MACROV’ in Eikon to access the app. 

Product preview of covid macro-vital app in Eikon

Access Eikon through a web browser for optimal connection to our industry leading market data, news and content. This access point is lighter on memory capacity and hence, more adaptable for laptops or personal computers. Customers can access Eikon Web now with existing user credentials or contact us for complimentary access.

Product preview of Global Markets Monitor in Eikon

Reuters is leveraging its global expertise in health and the pharmaceutical industry – and its deep sourcing with governments and health authorities worldwide – to bring readers and clients an unparalleled view of the fight against COVID-19. Scientists, governments and drugmakers have mounted a historic race to understand the new coronavirus and identify vaccines and treatments that will save lives worldwide. Reuters has been there at every turn, telling the inside story of that campaign and providing exclusive reporting on the advances and setbacks along the way. Follow all these updates in Eikon by searching for COVID and NEWS1 in the News Monitor. 

Not an Eikon user? Get in touch with us for complimentary access.


2021 Predictions

Reuters Breakingviews 2021 Predictions

Read a selection of articles brought to you by Reuters Breakingviews, including some pieces on COVID-19’s impact on markets and businesses.  

Providing service continuity

We have invested strongly in our business continuity and resilience measures.  Our top priority is the health of our people and our customers. We have control measures in place including business critical only travel restrictions. Refinitiv has well-established remote working capabilities which enable our employees to do their work and support our customers from anywhere in the world.   

We continue to adhere to the highest possible standards issued by health experts at the World Health Organization (WHO), Centers for Disease Control (CDC) and Johns Hopkins Hospital, as well as governments and regulators across our 190 countries of operation.

Remote access information

We encourage customers to contact their IT department, where applicable, before downloading or accessing any of the following Refinitiv products in order to obtain approval or company guidance.